Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 10 (October)

1. Lung cancer after treatment for Hodgkin's lymphoma: a systematic review.
   Lancet Oncol, 6(10): 773-9. [Abstract] [Full-text]
2. Nano neodymium oxide induces massive vacuolization and autophagic cell death in non-small cell lung cancer NCI-H460 cells.
   Biochem Biophys Res Commun, 337(1): 52-60. [Abstract] [Full-text]
3. The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy.
   Int J Radiat Oncol Biol Phys, 63(3): 885-91. [Abstract] [Full-text]
4. Novel breathing motion model for radiotherapy.
   Int J Radiat Oncol Biol Phys, 63(3): 921-9. [Abstract] [Full-text]
5. Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer.
   Genes Chromosomes Cancer, 44(4): 405-14. [Abstract] [Full-text]
6. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
   Int J Radiat Oncol Biol Phys, 63(3): 672-82. [Abstract] [Full-text]
7. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 63(3): 683-9. [Abstract] [Full-text]
8. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
   Int J Radiat Oncol Biol Phys, 63(3): 667-71. [Abstract] [Full-text]
9. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review.
   Int J Radiat Oncol Biol Phys, 63(3): 690-4. [Abstract] [Full-text]
10. The angiogenesis inhibitor NM-3 is active against human NSCLC xenografts alone and in combination with docetaxel.
    Cancer Chemother Pharmacol, 56(6): 610-4. [Abstract] [Full-text]
11. Paclitaxel and gemcitabine combination in a biweekly schedule in patients with advanced non small-cell lung cancer: a phase I study.
    Cancer Chemother Pharmacol, 56(6): 653-8. [Abstract] [Full-text]
12. Small-cell lung cancer.
    Lancet, 366(9494): 1385-96. [Abstract] [Full-text]
13. Alternate paths from epidermal growth factor receptor to Akt in malignant versus nontransformed lung epithelial cells: ErbB3 versus Gab1.
    Am J Respir Cell Mol Biol, 33(5): 490-9. [Abstract] [Full-text]
14. Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.
    Carcinogenesis, 26(11): 1947-55. [Abstract] [Full-text]
15. Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways.
    Carcinogenesis, 26(11): 1999-2009. [Abstract] [Full-text]
16. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.
    Biomaterials, 27(4): 660-9. [Abstract] [Full-text]
17. Computer-aided detection of peripheral lung cancers missed at CT: ROC analyses without and with localization.
    Radiology, 237(2): 684-90. [Abstract] [Full-text]
18. Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT.
    Radiology, 237(2): 675-83. [Abstract] [Full-text]
19. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.
    Radiology, 237(2): 395-400. [Abstract] [Full-text]
20. Hypoxemia during one-lung ventilation: jet ventilation of the middle and lower lobes during right upper lobe sleeve resection.
    Anesth Analg, 101(5): 1554-5. [Abstract] [Full-text]
21. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17.
    Histopathology, 47(5): 517-22. [Abstract] [Full-text]
22. Pediatric thyroid cancer.
    J Surg Oncol, 92(2): 130-3. [Abstract] [Full-text]
23. Computer-aided diagnosis of localized ground-glass opacity in the lung at CT: initial experience.
    Radiology, 237(2): 657-61. [Abstract] [Full-text]
24. Symptoms in patients with lung carcinoma: distinguishing distress from intensity.
    Cancer, 104(9): 2013-21. [Abstract] [Full-text]
25. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Cancer, 104(9): 1825-33. [Abstract] [Full-text]
26. Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.
    Cancer, 104(9): 1956-61. [Abstract] [Full-text]
27. Small cell carcinoma of the uterine corpus manifesting with visual dysfunction.
    Gynecol Oncol, 99(2): 504-6. [Abstract] [Full-text]
28. Global detection of molecular changes reveals concurrent alteration of several biological pathways in nonsmall cell lung cancer cells.
    Mol Genet Genomics, 274(2): 141-54. [Abstract] [Full-text]
29. An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.
    Br J Cancer, 93(9): 977-8. [Abstract] [Full-text]
30. WWOX gene restoration prevents lung cancer growth in vitro and in vivo.
    Proc Natl Acad Sci U S A, 102(43): 15611-6. [Abstract] [Full-text]
31. Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer.
    Int J Cancer, 117(6): 974-80. [Abstract] [Full-text]
32. Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorization.
    Oncogene, 24(47): 7105-13. [Abstract] [Full-text]
33. A moderate reduction of Bcl-x(L) expression protects against tumorigenesis; however, it also increases susceptibility to tissue injury.
    Oncogene, 24(47): 7120-4. [Abstract] [Full-text]
34. Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer.
    Cancer Chemother Pharmacol, 56(5): 521-8. [Abstract] [Full-text]
35. Specific induction of oxidative stress in terminal bronchiolar Clara cells during dimethylarsenic-induced lung tumor promoting process in mice.
    Cancer Lett, 230(1): 57-64. [Abstract] [Full-text]
36. Stimulation of cultured colon 26 cells with TNF-alpha promotes lung metastasis through the extracellular signal-regulated kinase pathway.
    Cancer Lett, 230(1): 47-56. [Abstract] [Full-text]
37. Cooperative cell-growth inhibition by combination treatment with ZD1839 (Iressa) and trastuzumab (Herceptin) in non-small-cell lung cancer.
    Cancer Lett, 230(1): 33-46. [Abstract] [Full-text]
38. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    J Clin Oncol, 23(31): 7974-84. [Abstract] [Full-text]
39. Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach.
    Lancet, 366(9496): 1558-60. [Abstract] [Full-text]
40. Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer).
    Lancet, 366(9496): 1527-37. [Abstract] [Full-text]
41. Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials.
    J Clin Oncol, 23(31): 8081-92. [Abstract] [Full-text]
42. Development of a shear force scanning near-field fluorescence microscope for biological applications.
    Ultramicroscopy, 105(1): 324-9. [Abstract] [Full-text]
43. Imaging of P-glycoprotein of H69/VP small-cell lung cancer lines by scanning near-field optical microscopy and confocal laser microspectrofluorometer.
    Ultramicroscopy, 105(1): 330-5. [Abstract] [Full-text]
44. The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells.
    Mutat Res, 579(1): 115-24. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.